The Genomics Facility provides CSHL Cancer Center members with many of the powerful genomic tools and techniques that have become available over the last several years. The facility, which initially started as a fluorescence in situ hybridization (FISH0 facility for gene mapping, has rapidly evolved in concert with the field, continuously expanding and updating the services that it offers. The facility currently offers the following services to the CSHL community: 1) Gene mapping by radiation hybrid (human and mouse); 2) BAC library screen (human and mouse); 3) YAC library screen (human and mouse); 4) Quantitative PCR analysis (Q-PCR) to detect deletions or amplifications of particular genomic loci in primary tumor samples and/or tumor cell lines; and 5) Isolation of C. elegans deletion mutant strains. In the near future, the facility plans to also offer a cDNA microarray screening service. The facility is headed by Dr. Michael Hengartner, who took over upon the departure of Dr. Carol Greider. Dr. Diane Esposito is in charge of day-to- day management of the facility, which is staffed by two technicians: Mr. Another Buglino (100%) and Jianli Gong (50%). The facility has been very useful in helping CSHL Cancer Center members to identify and characterize candidate oncogenes and tumor suppressor genes, and therefore is highly relevant to the mission of the CSHL Cancer Center.
| Chen, Xiaoyin; Sun, Yu-Chi; Church, George M et al. (2018) Efficient in situ barcode sequencing using padlock probe-based BaristaSeq. Nucleic Acids Res 46:e22 |
| Tonelli, Claudia; Chio, Iok In Christine; Tuveson, David A (2018) Transcriptional Regulation by Nrf2. Antioxid Redox Signal 29:1727-1745 |
| Kumar, Vijay; Rosenbaum, Julie; Wang, Zihua et al. (2018) Partial bisulfite conversion for unique template sequencing. Nucleic Acids Res 46:e10 |
| Lee, Je H (2018) Tracing single-cell histories. Science 359:521-522 |
| Alexander, Joan; Kendall, Jude; McIndoo, Jean et al. (2018) Utility of Single-Cell Genomics in Diagnostic Evaluation of Prostate Cancer. Cancer Res 78:348-358 |
| Huang, Yu-Han; Klingbeil, Olaf; He, Xue-Yan et al. (2018) POU2F3 is a master regulator of a tuft cell-like variant of small cell lung cancer. Genes Dev 32:915-928 |
| Tiriac, Hervé; Belleau, Pascal; Engle, Dannielle D et al. (2018) Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer. Cancer Discov 8:1112-1129 |
| Forcier, Talitha L; Ayaz, Andalus; Gill, Manraj S et al. (2018) Measuring cis-regulatory energetics in living cells using allelic manifolds. Elife 7: |
| Naguib, Adam; Mathew, Grinu; Reczek, Colleen R et al. (2018) Mitochondrial Complex I Inhibitors Expose a Vulnerability for Selective Killing of Pten-Null Cells. Cell Rep 23:58-67 |
| Aberle, M R; Burkhart, R A; Tiriac, H et al. (2018) Patient-derived organoid models help define personalized management of gastrointestinal cancer. Br J Surg 105:e48-e60 |
Showing the most recent 10 out of 380 publications
